Underwriting Research and Development Lead

New York Life Insurance Company (“New York Life” or “the company”) is the largest mutual life insurance company in the United States*. Founded in 1845, New York Life is headquartered in New York City, maintains offices in all fifty states, and owns Seguros Monterrey New York Life in Mexico.

 

New York Life is one of the most financially strong and highly capitalized insurers in the business. The company reported 2016 operating earnings of $1.954 billion. Total assets under management at year end 2016, with affiliates, totaled $538 billion.  As of year-end 2016, New York Life’s surplus was $23.336 billion**.  New York Life holds the highest possible financial strength ratings currently awarded to any life insurer from all four of the major ratings agencies: A.M. Best, A++; Fitch AAA; Moody’s Aaa; Standard & Poor’s AA+. (Source: Individual Third Party Ratings Report as of 8/17/16).

 

Financial strength, integrity and humanity—the values upon which New York Life was founded—have guided the company’s decisions and actions for over 170 years.

 

The Corporate Vice President (CVP) of Underwriting Research and Development will help create then refine underwriting and applications processes.  In this role, the successful incumbent will deliver key strategic capabilities and thought leadership to Underwriting innovation, research and development with the following responsibilities: 

 

  • Effectively influence cross-functional teams across a broad range of functional areas to enable development and execution of a multi-year UW R&D strategy
  • Contribute to the development of an Underwriting Rules Engine for NYL, including business requirements, technology development, testing and operational deployment
  • Provide subject matter expertise to evaluate Digital Health Data (DHD) from various sources for different underwriting and analytics use-cases in addition to executing proof of concept efforts with potential DHD partners
  • Collaborate effectively with UW production team to identify opportunities to operationalize DHD, support planning and execution of such operationalization efforts
  • Support different team efforts related to development and deployment of New Business and Underwriting platform
  • Evaluate vendors that can provide new data or services to New York Life by obtaining research data for cost/benefit studies and other research initiatives.
  • Support underwriting analytics efforts by liaising with NYL’s Center for Data Science and Analytics Department


Desired Characteristics and Skills: 

  • 7+ years of life insurance underwriting experience with strong technical underwriting skills and broad life insurance industry knowledge
  • Demonstrated track record of being able to successfully lead cross-functional teams and collaborate effectively across a broad range of functions and stakeholders
  • Familiarity with reinsurance underwriting manuals
  • Knowledge and understanding of underwriting platforms and solutions available in the industry is preferred
  • Experience with rules engines and automated underwriting systems including development as well as enhancement of rules/process is highly desirable
  • Understanding of predictive analytics is a plus
  • Demonstrated change management skills
  • Excellent business writing, presentation and communication skills

 

SF:LI-KR1  

SF:EF-KR1

 

 

EOE M/F/D/V

 

If you have difficulty using or interacting with any portions of this Web site due to incompatibility with an Assistive Technology, if you need the information in an alternative format, or if you have suggestions on how we can make this site more accessible, please contact us at: (212) 576-5811.

 

*Based on revenue as reported by “Fortune 500, ranked within Industries, Insurance: Life, Health (Mutual),” Fortune Magazine, June 17, 2016.  See http://fortune.com/fortune500/  for methodology.

**Total surplus, which includes the Asset Valuation Reserve, is one of the key indicators of the company’s long-term financial strength and stability and is presented on a consolidated basis of the company.

 

1. Operating earnings is the key measure use by management to track Company’s profitability from ongoing operations and underlying profitability of the business. This indicator is based on generally accepted accounting principles in the US (GAAP), with certain adjustments Company believes to be appropriate as a measurement approach (non GAAP), primarily the removal of gains or losses on investments and related adjustments.

 

2. Assets under management represent Consolidated Domestic and International insurance Company Statutory assets (cash and invested assets and separate account assets) and third party assets principally managed by New York Life Investment management Holdings LLC, a wholly owned subsidiary of New York Life Insurance Company.